Spots Global Cancer Trial Database for sarcoma,soft tissue
Every month we try and update this database with for sarcoma,soft tissue cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combined Modality Treatment of Sarcomas of the Extremities | NCT01985295 | Sarcoma,Soft Ti... | pazopanib | 18 Years - | The Netherlands Cancer Institute | |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma | NCT04595994 | Sarcoma,Soft Ti... | Selinexor | 18 Years - 80 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas | NCT05813808 | Sarcoma,Soft Ti... | ultra-low-dose ... | 18 Years - | Helsinki University Central Hospital | |
| A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) | NCT06263231 | Sarcoma,Soft Ti... | INT230-6 Eribulin Trabectedin Pazopanib | 18 Years - | Intensity Therapeutics, Inc. | |
| Combined Modality Treatment of Sarcomas of the Extremities | NCT01985295 | Sarcoma,Soft Ti... | pazopanib | 18 Years - | The Netherlands Cancer Institute | |
| Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma | NCT04910126 | Soft Tissue Sar... Neoplasms, Conn... Sarcoma Metasta... Sarcoma,Soft Ti... | Camrelizumab Adriamycin | 18 Years - 60 Years | Wuhan Union Hospital, China | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma | NCT04216953 | Sarcoma,Soft Ti... | Cobimetinib Atezolizumab | 12 Years - | Centre Leon Berard | |
| Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities | NCT04991883 | Sarcoma,Soft Ti... | case series rev... | 18 Years - | Istituto Ortopedico Rizzoli | |
| Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus | NCT05614375 | Sarcoma,Soft Ti... Nasal Cavity Ca... Paranasal Sinus... Surgery | endoscopic surg... | - | Eye & ENT Hospital of Fudan University | |
| A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma | NCT05886634 | Dedifferentiate... Soft Tissue Sar... Sarcoma,Soft Ti... Sarcoma Recurrent Dedif... Unresectable De... Metastatic Dedi... | Etrumadenant Zimberelimab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma | NCT05886634 | Dedifferentiate... Soft Tissue Sar... Sarcoma,Soft Ti... Sarcoma Recurrent Dedif... Unresectable De... Metastatic Dedi... | Etrumadenant Zimberelimab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma | NCT05167994 | Sarcoma,Soft Ti... Extremity Trunk Anlotinib Intensity-modul... Major Wound Com... | Anlotinib hydro... | 18 Years - | ChineseAMS | |
| Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction | NCT04347122 | Musculoskeletal... Sarcoma,Soft Ti... | Tranexamic Acid... | 18 Years - 90 Years | University of Kansas Medical Center | |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) | NCT06114004 | Sarcoma,Soft Ti... | Selinexor 20 MG Gemcitabine | 18 Years - 80 Years | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | NCT04673942 | Solid Tumor, Ad... Cancer Neoplasms Sarcoma Sarcoma,Soft Ti... Chondrosarcoma | AdAPT-001 Checkpoint Inhi... | 18 Years - | EpicentRx, Inc. | |
| Pemetrexed, Cisplatin With Soft Tissue Sarcoma | NCT04605770 | Sarcoma,Soft Ti... | pemetrexed+cisp... | 19 Years - | Yonsei University | |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors | NCT05851456 | Osteosarcoma Sarcoma Sarcoma,Soft Ti... Bone Tumor | Recombinant onc... | 14 Years - 75 Years | Shanghai Yunying Medical Technology | |
| Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas | NCT04248959 | Sarcoma,Soft Ti... Osteosarcoma | Multimodal preh... | 18 Years - 39 Years | University Health Network, Toronto | |
| PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) | NCT06074692 | Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone | Camrelizumab an... | 10 Years - 70 Years | Ruijin Hospital | |
| Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial | NCT06128863 | Neoadjuvant Immunotherapy Sarcoma,Soft Ti... Radiation Thera... | Pembrolizumab, ... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA | NCT05515575 | Sarcoma,Soft Ti... Sarcoma Uterus | Niraparib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases | NCT04887298 | Sarcoma,Soft Ti... Pulmonary Metas... | Liposomal Annam... | 18 Years - | Moleculin Biotech, Inc. | |
| Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas | NCT04248959 | Sarcoma,Soft Ti... Osteosarcoma | Multimodal preh... | 18 Years - 39 Years | University Health Network, Toronto | |
| MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma | NCT04216953 | Sarcoma,Soft Ti... | Cobimetinib Atezolizumab | 12 Years - | Centre Leon Berard | |
| Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma | NCT05235100 | Sarcoma,Soft Ti... Extremity Trunk Intensity-modul... Targetd Therapy Major Wound Com... | Apatinib Mesyla... | 18 Years - | ChineseAMS | |
| Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers | NCT05296564 | Sarcoma, Synovi... Sarcoma,Soft Ti... Melanoma Stage ... Triple Negative... Metastatic Canc... Non Small Cell ... Bladder Urothel... Neuroblastoma, ... Ovary Cancer | CYCLOPHOSPHAMID... Cyclophosphamid... HBI 0201-ESO TC... Aldesleukin | 18 Years - 70 Years | Hadassah Medical Organization | |
| Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy | NCT03474094 | Sarcoma,Soft Ti... | Pre-operative r... 2 cycles of ate... Pre-operative r... | 18 Years - | Centre Leon Berard | |
| Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma | NCT05894018 | Sarcoma,Soft Ti... Brachytherapy Poly(ADP-ribose... | Fluzoparib Radioactive par... | 18 Years - | Sun Yat-sen University | |
| In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors | NCT04616248 | Anatomic Stage ... Metastatic Brea... Prognostic Stag... Unresectable Br... Metastatic Mela... Unresectable Me... Cutaneous Squam... Merkel Cell Car... Soft Tissue Sar... Bone Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone | Anti-CD40 Agoni... Poly ICLC Radiation Thera... Recombinant Flt... | 18 Years - | University of Southern California | |
| Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction | NCT04347122 | Musculoskeletal... Sarcoma,Soft Ti... | Tranexamic Acid... | 18 Years - 90 Years | University of Kansas Medical Center | |
| GISAR German Interdisciplinary Sarcoma Registry | NCT04122872 | Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone Carcinosarcoma | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma | NCT05813327 | Soft Tissue Sar... Sts Sarcoma,Soft Ti... | ADI PEG20 Ifosfamide Radiotherapy Mesna | 18 Years - | Washington University School of Medicine | |
| Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities | NCT04991883 | Sarcoma,Soft Ti... | case series rev... | 18 Years - | Istituto Ortopedico Rizzoli | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma | NCT05167994 | Sarcoma,Soft Ti... Extremity Trunk Anlotinib Intensity-modul... Major Wound Com... | Anlotinib hydro... | 18 Years - | ChineseAMS | |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) | NCT06114004 | Sarcoma,Soft Ti... | Selinexor 20 MG Gemcitabine | 18 Years - 80 Years | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | |
| Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma | NCT04172805 | Sarcoma,Soft Ti... | anlotinib and t... | 18 Years - 70 Years | Sun Yat-sen University | |
| Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction | NCT04347122 | Musculoskeletal... Sarcoma,Soft Ti... | Tranexamic Acid... | 18 Years - 90 Years | University of Kansas Medical Center | |
| Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) | NCT06114004 | Sarcoma,Soft Ti... | Selinexor 20 MG Gemcitabine | 18 Years - 80 Years | Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | |
| (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas | NCT01949506 | Stage IV Adult ... Sarcoma,Soft Ti... | SBRT | 18 Years - | Medical College of Wisconsin | |
| (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas | NCT01949506 | Stage IV Adult ... Sarcoma,Soft Ti... | SBRT | 18 Years - | Medical College of Wisconsin | |
| Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas | NCT05813808 | Sarcoma,Soft Ti... | ultra-low-dose ... | 18 Years - | Helsinki University Central Hospital | |
| PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) | NCT06074692 | Sarcoma Sarcoma,Soft Ti... Sarcoma of Bone | Camrelizumab an... | 10 Years - 70 Years | Ruijin Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
